SCHEMBL3511527

SCHEMBL3511527

O=C(O)Cc1ccc(Oc2ccc(OC/C=C/c3ccc(C(F)(F)F)cc3)cc2)cc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PPARA Q07869 7/20 0.49
PPARD Q03181 7/20 0.49
PPARG P37231 5/20 0.49
SMN1; SMN2 Q16637 1/20 0.48
PSEN1 P49768 2/20 0.47
PTGES O14684 1/20 0.47
ALOX5 P09917 1/20 0.47
LTA4H P09960 1/20 0.46
EPHX2 P34913 1/20 0.46
CYP1A1 P04798 2/20 0.46
CYP1B1 Q16678 2/20 0.46
MAOB P27338 1/20 0.46
MAPK14 Q16539 1/20 0.44
PTGDR2 Q9Y5Y4 1/20 0.43
THRB P10828 1/20 0.43
PSEN2 P49810 1/20 0.42
APH1B Q8WW43 1/20 0.42
NCSTN Q92542 1/20 0.42
APH1A Q96BI3 1/20 0.42
PSENEN Q9NZ42 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3511529 1.00 PPARA (0.49) PPARAPPARDPPARGSMN1; SMN2PSEN1
SCHEMBL3508526 0.91 PPARG (0.49) PPARAPPARDPPARGSMN1; SMN2PSEN1
SCHEMBL3508522 0.91 PPARG (0.49) PPARAPPARDPPARGSMN1; SMN2PSEN1
SCHEMBL3507303 0.89 LTB4R (0.46) PPARAPPARDPPARGSMN1; SMN2PSEN1
SCHEMBL3507297 0.89 LTB4R (0.46) PPARAPPARDPPARGSMN1; SMN2PSEN1
SCHEMBL3508636 0.88 PPARG (0.50) PPARAPPARDPPARGSMN1; SMN2PSEN1
SCHEMBL3508633 0.88 PPARG (0.50) PPARAPPARDPPARGSMN1; SMN2PSEN1
SCHEMBL3505906 0.85 MAOB (0.53) PPARAPPARDPPARGCYP1A1CYP1B1
SCHEMBL3505901 0.85 MAOB (0.53) PPARAPPARDPPARGCYP1A1CYP1B1
SCHEMBL3508860 0.83 LTB4R (0.46) PPARAPPARDPPARGPSEN1PTGES

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100267778-A1 Diphenyl ether compound, process for producing the same, and use ONO PHARMACEUTICAL CO., LTD. (JP) 2010-10-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100267778-A1 Diphenyl ether compound, process for producing the same, and use PPARG, PPARD, PPARA PPARA 3/4885PPARD 2/4885PPARG 1/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.